These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 10984373)

  • 1. Mechanism of topical glucocorticoid treatment of hay fever: IL-5 and eosinophil activation during natural allergen exposure are suppressed, but IL-4, IL-6, and IgE antibody production are unaffected.
    Kita H; Jorgensen RK; Reed CE; Dunnette SL; Swanson MC; Bartemes KR; Squillace D; Blomgren J; Bachman K; Gleich GJ
    J Allergy Clin Immunol; 2000 Sep; 106(3):521-9. PubMed ID: 10984373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical steroid treatment of allergic rhinitis decreases nasal fluid TH2 cytokines, eosinophils, eosinophil cationic protein, and IgE but has no significant effect on IFN-gamma, IL-1beta, TNF-alpha, or neutrophils.
    Benson M; Strannegård IL; Strannegård O; Wennergren G
    J Allergy Clin Immunol; 2000 Aug; 106(2):307-12. PubMed ID: 10932075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of seasonal allergen exposure on mucosal IL-16 and CD4+ cells in patients with allergic rhinitis.
    Pullerits T; Lindén A; Malmhäll C; Lötvall J
    Allergy; 2001 Sep; 56(9):871-7. PubMed ID: 11551252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of topical fluticasone propionate on the mucosal allergic response induced by ragweed allergen and diesel exhaust particle challenge.
    Diaz-Sanchez D; Tsien A; Fleming J; Saxon A
    Clin Immunol; 1999 Mar; 90(3):313-22. PubMed ID: 10075860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing a model of seasonal allergic rhinitis and demonstrating dose-response to a topical glucocorticosteroid.
    Ahlström-Emanuelsson C; Persson CG; Svensson C; Andersson M; Hosszu Z; Akerlund A; Greiff L
    Ann Allergy Asthma Immunol; 2002 Aug; 89(2):159-65. PubMed ID: 12197572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bet v 1-specific IgA increases during the pollen season but not after a single allergen challenge in children with birch pollen-induced intermittent allergic rhinitis.
    Keen C; Johansson S; Reinholdt J; Benson M; Wennergren G
    Pediatr Allergy Immunol; 2005 May; 16(3):209-16. PubMed ID: 15853949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of anti-immunoglobulin E on nasal inflammation in patients with seasonal allergic rhinoconjunctivitis.
    Bez C; Schubert R; Kopp M; Ersfeld Y; Rosewich M; Kuehr J; Kamin W; Berg AV; Wahu U; Zielen S
    Clin Exp Allergy; 2004 Jul; 34(7):1079-85. PubMed ID: 15248853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.
    Masuyama K; Jacobson MR; Rak S; Meng Q; Sudderick RM; Kay AB; Lowhagen O; Hamid Q; Durham SR
    Immunology; 1994 Jun; 82(2):192-9. PubMed ID: 7927488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response.
    Tulic MK; Fiset PO; Christodoulopoulos P; Vaillancourt P; Desrosiers M; Lavigne F; Eiden J; Hamid Q
    J Allergy Clin Immunol; 2004 Feb; 113(2):235-41. PubMed ID: 14767435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th-2 type cytokine receptors in allergic rhinitis and in response to topical steroids.
    Wright ED; Christodoulopoulos P; Small P; Frenkiel S; Hamid Q
    Laryngoscope; 1999 Apr; 109(4):551-6. PubMed ID: 10201739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season.
    Wilson DR; Nouri-Aria KT; Walker SM; Pajno GB; O'Brien F; Jacobson MR; Mackay IS; Durham SR
    J Allergy Clin Immunol; 2001 Jun; 107(6):971-6. PubMed ID: 11398073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal interleukin-5, immunoglobulin E, eosinophilic cationic protein, and soluble intercellular adhesion molecule-1 in chronic sinusitis, allergic rhinitis, and nasal polyposis.
    Kramer MF; Ostertag P; Pfrogner E; Rasp G
    Laryngoscope; 2000 Jun; 110(6):1056-62. PubMed ID: 10852530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical treatment with aqueous solutions of rofleponide palmitate and budesonide in a pollen-season model of allergic rhinitis.
    Ahlström-Emanuelsson C; Andersson M; Persson C; Schrewelius C; Greiff L
    Clin Exp Allergy; 2004 May; 34(5):731-5. PubMed ID: 15144464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of nasal immunohistology in patients with seasonal rhinoconjunctivitis treated with topical steroids or specific allergen immunotherapy.
    Rak S; Heinrich C; Scheynius A
    Allergy; 2005 May; 60(5):643-9. PubMed ID: 15813810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapy.
    Ghaffar O; Laberge S; Jacobson MR; Lowhagen O; Rak S; Durham SR; Hamid Q
    Am J Respir Cell Mol Biol; 1997 Jul; 17(1):17-24. PubMed ID: 9224205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble adhesion molecules and cytokines in perennial allergic rhinitis.
    Liu CM; Shun CT; Cheng YK
    Ann Allergy Asthma Immunol; 1998 Aug; 81(2):176-80. PubMed ID: 9723565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between allergic inflammation and nasal airflow in children with seasonal allergic rhinitis.
    Ciprandi G; Tosca MA; Marseglia GL; Klersy C
    Ann Allergy Asthma Immunol; 2005 Feb; 94(2):258-61. PubMed ID: 15765742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ragweed-specific antibodies in bronchoalveolar lavage fluids and serum before and after segmental lung challenge: IgE and IgA associated with eosinophil degranulation.
    Peebles RS; Liu MC; Adkinson NF; Lichtenstein LM; Hamilton RG
    J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):265-73. PubMed ID: 9500761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
    Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W
    J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils.
    Lin H; Boesel KM; Griffith DT; Prussin C; Foster B; Romero FA; Townley R; Casale TB
    J Allergy Clin Immunol; 2004 Feb; 113(2):297-302. PubMed ID: 14767445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.